L’Oréal has acquired a majority stake in British skincare brand Medik8, reinforcing its commitment to the rapidly growing dermocosmetics segment. The move marks a strategic return to high-impact beauty mergers and acquisitions, following a relatively quiet period in the sector. While the financial terms remain undisclosed, the deal includes private equity firm Inflexion Continue Reading